Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
Dash D, Mody R, Ahmed N, Malan SR, Mody B.
Indian Heart J. 2022 Nov-Dec;74(6):450-457. doi: 10.1016/j.ihj.2022.10.193. Epub 2022 Nov 5.
Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.
Somsen YBO, Rissanen TT, Hoek R, Ris TH, Stuijfzand WJ, Nap A, Kleijn SA, Henriques JP, de Winter RW, Knaapen P.
Catheter Cardiovasc Interv. 2025 Feb;105(2):494-516. doi: 10.1002/ccd.31316. Epub 2024 Dec 11.
Clinical outcomes of a dedicated bifurcation stent system.
Sivalingam J, Mazhar MW, Chaddad RA, Fouladvand F, Cortese B.
Cardiovasc Revasc Med. 2024 Feb;59:21-26. doi: 10.1016/j.carrev.2023.08.015. Epub 2023 Aug 31.
[Interventional cardiology].
Albarrán A, Pinar E, Baz JA, Mauri J.
Rev Esp Cardiol. 2008 Feb;61 Suppl 1:72-85.
Riku S, Suzuki S, Yokoi T, Sakaguchi T, Yamamoto T, Jinno Y, Tanaka A, Ishii H, Inden Y, Murohara T.
Nagoya J Med Sci. 2022 May;84(2):352-365. doi: 10.18999/nagjms.84.2.352.
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel MA, Serruys PW, Gil RJ.
EuroIntervention. 2020 Oct 23;16(8):654-662. doi: 10.4244/EIJ-D-19-00361.
Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.
Capranzano P, Gargiulo G, Capodanno D, Longo G, Tamburino C, Ohno Y, Attizzani GF, La Manna A, Di Salvo M, Francaviglia B, Grasso C, Sgroi C, Tamburino C.
Minerva Cardioangiol. 2014 Jun;62(3):229-34.
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
Naganuma T, Kawamoto H, Panoulas VF, Latib A, Tanaka A, Mitomo S, Ruparelia N, Jabbour RJ, Chieffo A, Carlino M, Montorfano M, Colombo A.
Int J Cardiol. 2017 Nov 1;246:26-31. doi: 10.1016/j.ijcard.2017.03.123.
Very long-term outcomes following drug-eluting stent implantation for unprotected left main coronary artery stenosis: a single center experience.
Ielasi A, Latib A, Chieffo A, Takagi K, Mussardo M, Davidavicius G, Godino C, Carlino M, Montorfano M, Colombo A.
Rev Esp Cardiol (Engl Ed). 2013 Jan;66(1):24-33. doi: 10.1016/j.recesp.2012.06.026. Epub 2012 Oct 5.
The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experience.
Kern A, Gil RJ, Bojko K, Rzeszowski B, Jalali R, Górny J, Bil J.
Cardiol J. 2017;24(6):589-596. doi: 10.5603/CJ.a2017.0057. Epub 2017 May 25.
